pre 465 hybridization buffer Search Results


99
Thermo Fisher 465 serum albumin
465 Serum Albumin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/10__1128_slash_aac__02242___17-227-16-19?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
465 serum albumin - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
Santen SAS tapcom ® combination ophthalmic solution (taf/t-fdc; 0.0015% tafluprost and 0.5% timolol preserved with 0.001% bak)
Tapcom ® Combination Ophthalmic Solution (Taf/T Fdc; 0.0015% Tafluprost And 0.5% Timolol Preserved With 0.001% Bak), supplied by Santen SAS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pmc04934872-38-0-30?v=Santen+SAS
Average 90 stars, based on 1 article reviews
tapcom ® combination ophthalmic solution (taf/t-fdc; 0.0015% tafluprost and 0.5% timolol preserved with 0.001% bak) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Merck KGaA sodium hydroxide solution 221,465
Sodium Hydroxide Solution 221,465, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pmc06852021-89-6-10?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
sodium hydroxide solution 221,465 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Santen SAS timolol maleate gel-forming solution 0.5
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Timolol Maleate Gel Forming Solution 0.5, supplied by Santen SAS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pmc07055936-73-25-28?v=Santen+SAS
Average 90 stars, based on 1 article reviews
timolol maleate gel-forming solution 0.5 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Santen SAS topical β-blocker timolol maleate (tm)
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Topical β Blocker Timolol Maleate (Tm), supplied by Santen SAS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/10__5649_slash_jjphcs__42__645-18-27-35?v=Santen+SAS
Average 90 stars, based on 1 article reviews
topical β-blocker timolol maleate (tm) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
PAN - Biotech 10% fetal bovine 465 serum (fbs)
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
10% Fetal Bovine 465 Serum (Fbs), supplied by PAN - Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/10__1128_slash_jvi__00769___19-180-6-11?v=PAN+-+Biotech
Average 90 stars, based on 1 article reviews
10% fetal bovine 465 serum (fbs) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

97
Cytek Biosciences transcription factor staining buffer kit
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Transcription Factor Staining Buffer Kit, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/10__1128_slash_jvi__00664___19-205-14-19?v=Cytek+Biosciences
Average 97 stars, based on 1 article reviews
transcription factor staining buffer kit - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

90
Kestrel Biosciences running buffer (pbs and surfynol® 465 surfactant)
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Running Buffer (Pbs And Surfynol® 465 Surfactant), supplied by Kestrel Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pmc08248736-64-60-66?v=Kestrel+Biosciences
Average 90 stars, based on 1 article reviews
running buffer (pbs and surfynol® 465 surfactant) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Santen SAS timoptol® ophthalmic solution 0.25
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Timoptol® Ophthalmic Solution 0.25, supplied by Santen SAS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pm26782355-140-1-6?v=Santen+SAS
Average 90 stars, based on 1 article reviews
timoptol® ophthalmic solution 0.25 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
Thermo Fisher ripa lysis buffer
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Ripa Lysis Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/10__2139_slash_ssrn__4994085-238-22-26?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
ripa lysis buffer - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
Merck KGaA mes-sds buffer (50 mm mes, 50 mm tris base, 3.465 mm sds, and 1 mm edta)
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Mes Sds Buffer (50 Mm Mes, 50 Mm Tris Base, 3.465 Mm Sds, And 1 Mm Edta), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pm37595036-382-21-45?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
mes-sds buffer (50 mm mes, 50 mm tris base, 3.465 mm sds, and 1 mm edta) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology buffer
Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the <t>timolol</t> group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.
Buffer, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pre+465+hybridization+buffer/pm19287985-54-11-16?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
buffer - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the timolol group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.

Journal: Journal of Glaucoma

Article Title: Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial

doi: 10.1097/IJG.0000000000001285

Figure Lengend Snippet: Flowchart of participant recruitment and treatment assignment. A total of 68 eyes were randomized to 2 treatment groups: 36 eyes to the brimonidine group and 32 eyes to the timolol group. During the follow-up period, 11 patients in the brimonidine group and 7 patients in the timolol group dropped out of the study for various reasons. We performed an ITT analysis on all 56 patients (26 patients in the brimonidine group and 30 patients in the timolol group) who completed the 24-month examination schedule, regardless of their adherence to the allocated medication. ITT indicates intent to treat; PPS, per protocol set.

Article Snippet: Study Treatment Patients were assigned to treatment with brimonidine tartrate 0.1% (brimonidine; AIPHAGAN; Senju Pharmaceutical Co. Ltd, Osaka, Japan) or timolol maleate gel-forming solution 0.5% (timolol; TIMOPTOL XE; Santen Pharmaceutical Co. Ltd, Osaka, Japan) at random by severity of the visual field defect (mild: MD>−6 dB, moderate: −6 dB ≥MD ≥−12 dB, severe: MD<−12 dB).

Techniques:

Kaplan-Meier survival estimates of the cumulative probability of visual field progression. The numbers of subjects with Guided Progression Analysis progression were 1 and 7 in the brimonidine and timolol groups, respectively. This is a statistically significant result according to the log-rank test (P=0.0198).

Journal: Journal of Glaucoma

Article Title: Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial

doi: 10.1097/IJG.0000000000001285

Figure Lengend Snippet: Kaplan-Meier survival estimates of the cumulative probability of visual field progression. The numbers of subjects with Guided Progression Analysis progression were 1 and 7 in the brimonidine and timolol groups, respectively. This is a statistically significant result according to the log-rank test (P=0.0198).

Article Snippet: Study Treatment Patients were assigned to treatment with brimonidine tartrate 0.1% (brimonidine; AIPHAGAN; Senju Pharmaceutical Co. Ltd, Osaka, Japan) or timolol maleate gel-forming solution 0.5% (timolol; TIMOPTOL XE; Santen Pharmaceutical Co. Ltd, Osaka, Japan) at random by severity of the visual field defect (mild: MD>−6 dB, moderate: −6 dB ≥MD ≥−12 dB, severe: MD<−12 dB).

Techniques: